-
Purposemonomeric photosensitizing fluorescent protein for chromophore-assisted light inactivation
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 53234 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRSET-B
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 2900
- Total vector size (bp) 3600
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemonomeric photosensitizing fluorescent protein for chromophore-assisted light inactivation
-
Alt namemKillerRed
-
SpeciesSynthetic
-
Insert Size (bp)700
-
GenBank IDAB522905
-
Tags
/ Fusion Proteins
- 6xHis (N terminal on backbone)
- T7 tag (N terminal on backbone)
- Xpress tag (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7 terminal (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
SuperNova/pRSETB was a gift from Takeharu Nagai (Addgene plasmid # 53234 ; http://n2t.net/addgene:53234 ; RRID:Addgene_53234) -
For your References section:
SuperNova, a monomeric photosensitizing fluorescent protein for chromophore-assisted light inactivation. Takemoto K, Matsuda T, Sakai N, Fu D, Noda M, Uchiyama S, Kotera I, Arai Y, Horiuchi M, Fukui K, Ayabe T, Inagaki F, Suzuki H, Nagai T. Sci Rep. 2013;3:2629. doi: 10.1038/srep02629. 10.1038/srep02629 PubMed 24043132